138 related articles for article (PubMed ID: 3859461)
1. Evidence of fibrinogen breakdown by leukocyte enzymes in a patient with acute promyelocytic leukemia.
Sterrenberg L; Haak HL; Brommer EJ; Nieuwenhuizen W
Haemostasis; 1985; 15(2):126-33. PubMed ID: 3859461
[TBL] [Abstract][Full Text] [Related]
2. Increased proteolysis of antithrombin III Vicenza during disseminated intravascular coagulation in acute leukemia.
Castaman G; Ruggeri M; Rodeghiero F
Thromb Res; 1989 Sep; 55(5):661-4. PubMed ID: 2814948
[No Abstract] [Full Text] [Related]
3. Assessment of coagulation disorders in patients with acute leukemia before and after cytostatic treatment.
Chojnowski K; Wawrzyniak E; Treliński J; Niewiarowska J; Cierniewski C
Leuk Lymphoma; 1999 Dec; 36(1-2):77-84. PubMed ID: 10613452
[TBL] [Abstract][Full Text] [Related]
4. Levels of thrombin-antithrombin III complex in plasma in cases of acute promyelocytic leukemia.
Asakura H; Saito M; Ito K; Jokaji Y; Uotani C; Kumabashiri I; Matsuda T
Thromb Res; 1988 Jun; 50(6):895-9. PubMed ID: 3166241
[No Abstract] [Full Text] [Related]
5. Granulocyte enzyme mediated degradation of human fibrinogen in plasma in vitro.
Sterrenberg L; Gravesen M; Haverkate F; Nieuwenhuizen W
Thromb Res; 1983 Sep; 31(5):719-28. PubMed ID: 6557687
[TBL] [Abstract][Full Text] [Related]
6. A continuous spectrum of hypercoagulability exists in acute nonlymphoblastic leukemia.
Sureda A; García Frade LJ; Torrado MC; García Laraña J; García Avello A
Acta Haematol; 1992; 88(2-3):100-4. PubMed ID: 1281598
[TBL] [Abstract][Full Text] [Related]
7. Antithrombin III and anti-activated factor X activity in patients with acute promyelocytic leukemia and disseminated intravascular coagulation treated with heparin.
Sandler RM; Liebman HA; Patch MJ; Teitelbaum A; Levine AM; Feinstein DI
Cancer; 1983 Feb; 51(4):681-5. PubMed ID: 6571800
[TBL] [Abstract][Full Text] [Related]
8. Coagulation disorders associated with acute promyelocytic leukemia: corrective effect of all-trans retinoic acid treatment.
Dombret H; Scrobohaci ML; Ghorra P; Zini JM; Daniel MT; Castaigne S; Degos L
Leukemia; 1993 Jan; 7(1):2-9. PubMed ID: 8418375
[TBL] [Abstract][Full Text] [Related]
9. Anticoagulant properties of purified X-like fragments of human fibrinogen produced by degradation with leukocyte elastase.
Sterrenberg L; van Liempt GJ; Nieuwenhuizen W; Hermans J
Thromb Haemost; 1984 Jul; 51(3):398-402. PubMed ID: 6238443
[TBL] [Abstract][Full Text] [Related]
10. Immunochemical discrimination of leukocyte elastase from plasmic degradation products of fibrinogen.
Plow EF; Gramse M; Havemann K
J Lab Clin Med; 1983 Dec; 102(6):858-69. PubMed ID: 6227673
[TBL] [Abstract][Full Text] [Related]
11. [Prevention and early diagnosis of disseminated intravascular coagulation].
Matsuda T
Nihon Naika Gakkai Zasshi; 1993 Sep; 82(9):1375-82. PubMed ID: 8245630
[No Abstract] [Full Text] [Related]
12. Increase in the D-dimer levels during treatment in patients with acute myelogenous leukemia.
Velasco F; Torres A; Rojas R; Alvarez MA; Gomez P; Castillo D
Haemostasis; 1992; 22(3):117-23. PubMed ID: 1427455
[TBL] [Abstract][Full Text] [Related]
13. [Advancement in the diagnosis of disseminated intravascular coagulation for the surgeon].
Ohsato K; Okamoto K
Nihon Rinsho; 1993 Jan; 51(1):50-5. PubMed ID: 8381885
[TBL] [Abstract][Full Text] [Related]
14. Elastase mediated fibrinolysis in acute promyelocytic leukemia.
Oudijk EJ; Nieuwenhuis HK; Bos R; Fijnheer R
Thromb Haemost; 2000 Jun; 83(6):906-8. PubMed ID: 10896247
[TBL] [Abstract][Full Text] [Related]
15. [Atypical defibrination syndromes and acute leukemias with a t(9,22) translocation, apropos of 2 cases].
Meddeb B; Guermazi S; Hafsia R; Ben Abid H; Gouider E; Ben Lakhal R; Bel Haj Ali Z; Ben Othman T; Jeddi R; Dellagi K; Hafsia A
Pathol Biol (Paris); 2001 Apr; 49(3):232-6. PubMed ID: 11367558
[TBL] [Abstract][Full Text] [Related]
16. [Progress in diagnosis of disseminated intravascular coagulation (DIC)--diagnostic criteria of DIC].
Koyama T; Aoki N
Nihon Rinsho; 1993 Jan; 51(1):43-9. PubMed ID: 8433527
[TBL] [Abstract][Full Text] [Related]
17. [Intravascular coagulation in acute promyelocytic leukemia: analysis of coagulation and fibrinolysis parameters].
Chuecas F; Loredo E; Muñoz B; Alfaro J; Grebe G; Lira P
Rev Med Chil; 1991 Sep; 119(9):984-9. PubMed ID: 1845106
[TBL] [Abstract][Full Text] [Related]
18. The proteinase inhibitor complexes (antithrombin III-thrombin, alpha 2antiplasmin-plasmin and alpha 1antitrypsin-elastase) in septicemia, fulminant hepatic failure and cardiac shock: value for diagnosis and therapy control in DIC/F syndrome.
Egbring R; Seitz R; Blanke H; Leititis J; Kesper HJ; Burghard R; Fuchs G; Lerch L
Behring Inst Mitt; 1986 Feb; (79):87-103. PubMed ID: 2424425
[TBL] [Abstract][Full Text] [Related]
19. Demonstration of granulocytic proteases in plasma of patients with acute leukemia and septicemia with coagulation defects.
Egbring R; Schmidt W; Fuchs G; Havemann K
Blood; 1977 Feb; 49(2):219-31. PubMed ID: 299817
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of hypercoagulability after remission induction chemotherapy of acute leukemia.
Hiller E; Riess H; Hafter R; Graeff H
Blut; 1980 Nov; 41(5):359-66. PubMed ID: 7437530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
